|
25.1.2008 |
EN |
Official Journal of the European Union |
C 19/12 |
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 December 2007 to 31 December 2007
(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council (1) or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council (2) )
(2008/C 19/05)
— Issuing, maintenance or modification of a national marketing authorisation
|
Date of the decision |
Name(s) of the medicinal product |
Holder(s) of the marketing authorization |
Member State concerned |
Date of notification |
|||||
|
18.12.2007 |
Tracleer |
|
This Decision is addressed to the Member States |
19.12.2007 |
|||||
|
18.12.2007 |
Silapo |
|
This Decision is addressed to the Member States |
19.12.2007 |
|||||
|
18.12.2007 |
Retacrit |
|
This Decision is addressed to the Member States |
19.12.2007 |
|||||
|
19.12.2007 |
MabCampath |
|
This Decision is addressed to the Member States |
20.12.2007 |
(1) OJ L 311, 28.11.2001, p. 67.
(2) OJ L 311, 28.11.2001, p. 1.